Insurer Battles Physician Group

Data are scarce on the impact that breast cancer among mothers has on their children and their emotional development due to parenting stress and maternal depression.

In part 2 of this 2-part podcast, a panel of experts discusses implementation biosimilars in biologic-naïve patients, auto-substitution, and more.

If finalized, these proposals will generally take effect on January 1, 2025, unless otherwise noted.

In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.

A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.

The Biden administration plans to utilize the Defense Production Act to boost essential medicine manufacturing; a landmark case challenges Texas abortion laws; reports of the BA.2.86 variant of SARS-CoV-2 have nearly tripled in the United States.